Clinical trial
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal…
NCT00119691 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00119691 |
|---|---|
| Title | Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction |
| Official title | Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Scios, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure, Renal Insufficiency |
| Intervention type | Drug |
| Interventions | Nesiritide |
| Enrollment | 34 |
| Start date | Apr 1, 2003 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Jul 14, 2005 |
| Last update posted | Sep 12, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: